Encell Co., Ltd. (456070) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Encell Co., Ltd. (456070:KRX), powered by AI.

Current Price
₩14,360
P/E Ratio
-9.8
Market Cap
158.4B
Sector
Healthcare
What is the Encell Co., Ltd. stock price forecast?

Encell Co., Ltd. is currently trading at ₩14,360. View real-time AI analysis on Alpha Lenz.

What is Encell Co., Ltd. insider trading activity?

View the latest insider trading data for Encell Co., Ltd. on Alpha Lenz.

What is Encell Co., Ltd.'s P/E ratio?

Encell Co., Ltd.'s P/E ratio is -9.8.

Encell Co., Ltd.

KRX · 456070
₩14,360-550(-3.69%)Market closedKRX regular session 09:00–15:30 KST
Ask about Encell Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Encell Co., Ltd. trades at a P/E of -9.8 (undervalued) with modest ROE of -36.8%.

Ask for details

Company Overview

Encell Co., Ltd. is a company specializing in the biotechnology and pharmaceuticals sectors. Its primary function is to develop and produce innovative therapies and health solutions aimed at addressing various medical needs. With a strong emphasis on research and development, Encell Co., Ltd. engages in creating novel drugs and treatment methodologies that have the potential to significantly impact the healthcare industry. The company collaborates extensively with research institutions and medical professionals to streamline its development processes and enhance efficacy in its offerings. As a participant in the fast-evolving biotech and pharmaceutical industries, Encell Co., Ltd. plays a vital role in the global efforts to improve health outcomes and advance medical technologies. Headquartered in South Korea, it is part of a significant financial market segment that sees continuous influxes of investment directed towards innovative health solutions, reflecting its importance in contributing to public health and scientific advancement.

CEO장종욱
SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

₩158,372,376,120Market Cap
₩5,258,687,300Revenue
11.03MShares Out
0Employees

Margins

-45.68%Gross
-233.57%EBITDA
-339.26%Operating
-321.54%Pre-Tax
-306.30%Net

Valuation

-9.83P/E
4.02P/B
30.12EV/Sales
-10.82EV/EBITDA
-11.87P/FCF

Growth (CAGR)

-10.63%Rev 3Yr
30.23%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-26.97%ROA
-36.79%ROE
-27.28%ROIC

Financial Health

₩38,509,961,610Cash & Cash Equivalents
₩-14,200,734,680Net Debt
61.69%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Encell Co., Ltd. (ticker: 456070) is a company listed on KRX in the Healthcare sector (Biotechnology). Market cap is $158.4B.

The current price is ₩14,360 with a P/E ratio of -9.83x and P/B of 4.02x.

ROE is -36.79% and operating margin is -339.26%. Annual revenue is $5.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Encell Co., Ltd. (Healthcare) Stock Forecast & Analysis ₩14,360 | Alpha Lenz